Astria Therapeutics Inc

ATXSStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$12.59

Today

+0.1%

YTD

-3.6%

About

Astria Therapeutics Inc is a name in the biopharmaceutical industry, recognised for its commitment to developing and delivering innovative treatments for allergic and immunological diseases. Although the firm is based in the US, Astria Therapeutics specialises in providing breakthrough healthcare solutions for various unmet medical needs worldwide. Situated in the biotech sector, Astria Therapeutics plays a pivotal role in orchestrating change and innovation. The company provides a vast array of services aimed at improving patient care, most famously through its lead product candidate, STAR-0215. Stay up to date on the ATXS share price by adding it to your eToro watchlist.

Price chart

Closing price history for ATXS (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-5.85

P/S (TTM)1033.59

P/B (TTM)5.15

Market cap$718.13M

Cap tierSmall-cap

Industry avg P/E-7.37

Profitability

Gross marginUnknown

EBIT margin-19335.69%

Net margin-4482.01%

ROE-64.56%

ROA-39.16%

Earnings & Revenue

Revenue (TTM)$706,000.00

Revenue growth (1Y)Unknown

EPS (TTM)-$2.15

Free cash flow$-120.32M

Total debt$4.46M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.24

Employees78

Next earnings18 Mar '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.